16th Feb 2026 15:17
(Alliance News) - Physiomics PLC on Monday saw its shares decline as it posted a widened interim loss, but expressed optimism on hitting market expectations for the full-year.
Oxford, England-based Physiomics is a mathematical modelling company supporting the development of new therapeutics and personalised medicine solutions.
Its shares were trading 13% lower at 0.57 pence on Monday afternoon in London.
Physiomics reported a pretax loss of GBP326,000 for the six months ended December 31, widened from GBP249,000 a year earlier.
Revenue rose 52% to GBP498,000 from GBP329,000, and total income advanced 49% to GBP528,000 from GBP354,000.
Physiomics said its ongoing expansion of service offerings into discovery, later clinical phases and new therapeutics areas has been a "significant contributor" to its growth.
The company also noted the "important development" of launching of its Biometrics service line and securing its first four Biometrics contracts.
Operating expenses rose 42% to GBP855,000 from GBP603,000.
Looking ahead, Physiomics guides total income growth of 27% for the financial year ending June, in line with market expectations. For financial 2025, total income was GBP834,156.
Physiomics also expects second half operating expenses to come in "significantly lower" than in the first half. It added that this will enable it to remain on track to meet market expectations of a 24% decline in loss after tax.
Loss after tax in financial 2025 was GBP415,254.
"The directors expect the company to meet current market expectations for the full year (June 2026); and remain optimistic that this will also be the highest ever full year total income in the company's history," said Physiomics.
"Even though the operating loss in the first half of this financial year does not align with the market expectations for the full year, the board believes that a reduced reliance on external contractors in the second half, along with a strong pipeline, should allow the company to meet the full year market expectations with respect to the total income and loss after tax. We expect to be at the lower end of the market expectation for the FY cash position."
By Christopher Ward, Alliance News reporter
Comments and questions to [email protected]
Copyright 2026 Alliance News Ltd. All Rights Reserved.
Related Shares:
Physiomics